Expectations trend
FY2028 · fiscal year ending 2028-09-30 · fmp
$-0.04 → $-0.04 · observed estimates
Richtech Robotics, Inc. (RR)
NASDAQIndustrialsIndustrial - MachinerySnapshot 2026-11-04
$0.90-3.13%
Close 2026-11-04 · 1-day change
NASDAQIndustrialsIndustrial - MachinerySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for RR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Improve operating income from current losses | The company targets improving operating income, though it declined from -$4.6M in 2025-Q4 to -$11.8M in 2026-Q1. | Broken | Operating income remains below -$10M in FY27 | Operating income: $-13.267M FY2026-Q3; GAAP. Published target: Operating income improves toward less negative or break-even levels. Annual target cannot be compared with a quarterly or TTM observation. Aug 19, 2026-13,267,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-09-30 · fmp
$-0.04 → $-0.04 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
RR is a speculative growth business with a high-risk profile, not a proven compounder. Its thesis is in a watch state: revenue is growing, but recent financial performance is weak and management has not made progress on its long-running operating-income priority.
The evidence snapshot provides no valuation or market-expectations data, so whether RR is cheap or expensive versus peers cannot be assessed. Recent price reaction was down, but that alone does not show what expectations are already reflected.
Near term, the business faces a weak sector backdrop and recession concerns, while its momentum measure fell sharply. Revenue rose to $1.37 million in 2026-Q3, but operating income worsened to a loss of $13.3 million, despite eight quarters of stated focus on improvement.
Over the next one to three years, the thesis depends on whether revenue growth and the expansion of AI infrastructure and robotics capabilities translate into better operating results. Sector signals also matter: continued strength from industrial bellwethers could support the backdrop, while weaker results or a weakening jobs trend could add pressure.
RR's multi-year view has some growth and expansion evidence, but persistent losses, volatile execution, and high risk leave the thesis fragile. The evidence does not establish whether valuation already reflects these weaknesses. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Resolve Nasdaq compliance and financial restatement issues | A supporting condition in Richtech Robotics, Inc.'s published investment case. The stated target is No further Nasdaq notices or financial restatements. | Under Pressure | New Nasdaq noncompliance notices or financial restatements occur | 2 new compliance events vs 0 target Nasdaq notice for delayed 10-Q and Audit Committee conclusion to restate FY2024/2025 financial statements. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Increase revenue from recent declines | A primary condition in Richtech Robotics, Inc.'s published investment case. The stated target is Revenue grows from $8.6M in 2026 to $15.3M in 2027. | Broken | Revenue fails to grow above $10M in FY27 | Revenue: $1.373M FY2026-Q3; GAAP. Published target: Revenue grows from $8.6M in 2026 to $15.3M in 2027. Annual target cannot be compared with a quarterly or TTM observation. Aug 19, 20261,373,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Complete strategic acquisitions | Richtech Robotics aims to complete strategic acquisitions, shown by the recent deal on 2026-06-03. | Improving | No further acquisitions completed within next 4 quarters | 1 acquisition completed (Jun 2026) vs target of continued M&A RR completed an asset acquisition in June 2026 and announced a strategic collaboration in May 2026. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.01B → $0.01B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-10-01 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-02 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-03 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-04 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-05 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-06 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-07 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-08 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-09 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-10 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-11 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-12 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-13 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-14 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-15 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-16 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-17 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-18 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-19 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-20 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-21 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-22 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-23 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-24 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-25 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-26 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-27 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-28 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-29 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-30 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-10-31 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-11-01 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-11-02 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-11-03 | $-0.04 | $8,430,000 | 1 / 1 |
| 2026-11-04 | $-0.04 | $8,430,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.